Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 24Thoracic 17Other hematologic neoplasm 17Gastrointestinal 14Plasma cell 9Head & Neck 9Genitourinary 9Sarcoma 7Myeloid 7Gynecologic 6CNS 4NET 3Endocrine 3Dermatologic 3Breast 3Other neoplasm 2Tumor-Agnostic 1Other solid neoplasm 1

Conditions

Neoplasms 1232Neoplasm Metastasis 297Carcinoma 45Adenocarcinoma 35Carcinoma, Squamous Cell 17Neoplasms, Unknown Primary 4Neoplasms by Site 3Neoplasm, Residual 3Neoplasms by Histologic Type 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neoplasms by Histologic Type × Tumor-Agnostic × Clear all
NCT06175780 2023-12-26

Phase I Study of KY-0118 in Subjects With Locally Advanced or Metastatic Solid Tumors

Novatim Immune Therapeutics (Zhejiang) Co., Ltd.

Phase 1 Unknown
189 enrolled
Tumor-Agnostic

Neoplasms, Neoplasms by Histologic Type

Data powered by HemOnc (CC BY 4.0) Colophon âš¡